Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/SNN
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Smith & Nephew plc (SNN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Smith+Nephew (SNN) trades at $27.72, near its 52-week low of $27.05 (Defense World, 2026-09-25), with a slight 0.18% daily gain. The stock shows a mixed technical picture with a bullish overall signal but bearish moving averages, while fundamentals reflect steady revenue growth to $6.16B in 2025 and improving net income margins above 10%. Recent product launches like the EVOS PELVIC System (GlobeNewsWire, 2026-09-23) highlight innovation, but analyst sentiment is cautious with 65% hold ratings.
SNN presents a value opportunity with a reasonable P/E of 18.95 and strong cash flow, but risks include competitive pressures noted by UBS (2026-08-25) and execution concerns after the CFO's departure. The stock's proximity to lows may attract bargain hunters, yet growth skepticism and debt levels warrant caution for near-term volatility.
Read full analysis

Key Stats

  • Market Cap
    $11.60B
  • Volume
    971,836
  • Sector
    Health
  • 52W High
    $37.17
  • 52W Low
    $26.42
  • Typical Hold Time
    121 Days
  • Enterprise Value
    $14.63B
  • Div Yield
    2.85%
  • Trading Activity
    -
$27.9
52W Low: $26.42
02 Oct 2026
52W High: $37.17
22 Oct 2025

Track Smith & Nephew plc (SNN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Smith & Nephew plc has traded between a low of $26.42 and a high of $37.17, highlighting its annual price range. Buy and sell Smith & Nephew plc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Most Recent News

Content is generated by Aura AI

Honey Badger Silver reports high-grade polymetallic samples at Yava, reviving interest in northern Canada's VMS deposits.

Honey Badger Silver announced promising assay results from its first exploration program at the Yava Project in Nunavut, revealing high-grade silver, copper, gold, zinc, and lead samples. This marks the first systematic work at Yava in nearly two dec...

Market News
1 hour ago
Mining Stocks News Commentary
Bullish
news icon
Honey Badger Silver reports high-grade polymetallic samples at Yava, reviving interest in northern Canada's VMS deposits.

Brasil DNA Virtual Roadshow connects 187 travel pros with 90+ Brazilian suppliers, boosting tourism ties.

The Brasil DNA Virtual Roadshow held in October 2026 brought together 187 travel professionals from the US and Canada, facilitating 551 connections with over 90 Brazilian tourism suppliers across 54 booths. The event generated 741 leads and featured ...

Market News
1 hour ago
Not Specified
Neutral
Brasil DNA Virtual Roadshow connects 187 travel pros with 90+ Brazilian suppliers, boosting tourism ties.

Remittix sets Nov 24 launch for RTX token as Ethereum staking expands and Cardano hits transaction record

Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...

Market News
3 hours ago
Remittix
Bullish
news icon
Remittix sets Nov 24 launch for RTX token as Ethereum staking expands and Cardano hits transaction record
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $11.60B
  • Volume
    971,836
  • Sector
    Health
  • 52W High
    $37.17
  • 52W Low
    $26.42
  • Typical Hold Time
    121 Days
  • Enterprise Value
    $14.63B
  • Div Yield
    2.85%
  • Trading Activity
    -
$27.9
52W Low: $26.42
02 Oct 2026
52W High: $37.17
22 Oct 2025

Track Smith & Nephew plc (SNN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Smith & Nephew plc has traded between a low of $26.42 and a high of $37.17, highlighting its annual price range. Buy and sell Smith & Nephew plc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!